Idiopathic Choroidal Neovascularization in Young Patients: Report of Two Cases
Rolyf Keith Awore Adjatin *
Department of Ophthalmology, Hôpital Militaire d’Instruction Mohamed V, Rabat, Morocco.
Yosra Azaro
Department of Ophthalmology, Hôpital Militaire d’Instruction Mohamed V, Rabat, Morocco.
Youssef Achegri
Department of Ophthalmology, Hôpital Militaire d’Instruction Mohamed V, Rabat, Morocco.
Hatim Boui
Department of Ophthalmology, Hôpital Militaire d’Instruction Mohamed V, Rabat, Morocco.
Yassine Mouzari
Department of Ophthalmology, Hôpital Militaire d’Instruction Mohamed V, Rabat, Morocco.
Abdelbarre Oubaaz
Department of Ophthalmology, Hôpital Militaire d’Instruction Mohamed V, Rabat, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Idiopathic choroidal neovascularization (ICNV) in young patients represents a rare but visually threatening condition characterized by the presence of subfoveal or juxtafoveal neovascular membranes in the absence of identifiable predisposing factors such as high myopia, inflammatory disorders, trauma, or hereditary retinal disease. The advent of anti-VEGF therapy has dramatically changed the visual prognosis of these patients. We report two cases of ICNV managed at the Department of Ophthalmology, Hôpital Militaire d’Instruction Mohamed V, Rabat, Morocco, emphasizing the role of multimodal imaging and the efficacy of intravitreal anti-VEGF therapy.
Keywords: Idiopathic choroidal neovascularization, young patients, anti-VEGF therapy, OCT, fluorescein angiography